BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 16638847)

  • 21. Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.
    Sclabas GM; Fujioka S; Schmidt C; Li Z; Frederick WA; Yang W; Yokoi K; Evans DB; Abbruzzese JL; Hess KR; Zhang W; Fidler IJ; Chiao PJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):440-9. PubMed ID: 15701826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bystin in perineural invasion of prostate cancer.
    Ayala GE; Dai H; Li R; Ittmann M; Thompson TC; Rowley D; Wheeler TM
    Prostate; 2006 Feb; 66(3):266-72. PubMed ID: 16245277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
    Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
    Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR.
    Ramachandran V; Arumugam T; Hwang RF; Greenson JK; Simeone DM; Logsdon CD
    Cancer Res; 2007 Mar; 67(6):2666-75. PubMed ID: 17363587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.
    Ide Y; Miyoshi E; Nakagawa T; Gu J; Tanemura M; Nishida T; Ito T; Yamamoto H; Kozutsumi Y; Taniguchi N
    Biochem Biophys Res Commun; 2006 Mar; 341(2):478-82. PubMed ID: 16434023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
    Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
    Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of YPEL1 in pancreatic cancer cell lines and tissues.
    Abiatari I; Kiladze M; Kerkadze V; Friess H; Kleeff J
    Georgian Med News; 2009 Oct; (175):60-2. PubMed ID: 19893129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.
    Hippo Y; Yashiro M; Ishii M; Taniguchi H; Tsutsumi S; Hirakawa K; Kodama T; Aburatani H
    Cancer Res; 2001 Feb; 61(3):889-95. PubMed ID: 11221876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100P promotes pancreatic cancer growth, survival, and invasion.
    Arumugam T; Simeone DM; Van Golen K; Logsdon CD
    Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
    Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivin expression and its clinical significance in pancreatic cancer.
    Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
    BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of ONECUT1 expression in human pancreatic cancer cells.
    Jiang X; Zhang W; Kayed H; Zheng P; Giese NA; Friess H; Kleeff J
    Oncol Rep; 2008 Jan; 19(1):157-63. PubMed ID: 18097590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
    Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
    Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
    Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
    Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
    Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
    Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
    Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
    Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.